• 00:59 1.
    index 1
  • 00:27 2.
    Slide 2
  • 01:35 3.
    Introduction
  • 01:17 4.
    Slide 4
  • 00:39 5.
    Examination of universally expressed circRNAs
  • 02:11 6.
    Treated HeLa cells with 8 stressors followed by the examination of universally expressed circRNAs
  • 01:01 7.
    circRNAs are degraded upon Poly I:C treatment
  • 00:00 8.
    Global reduction of high confidence circRNAs upon poly(I:C) for 6 h (C) or EMCV for 24 h
  • 00:59 9.
    circRNAs are degraded upon Poly I:C treatment
  • 01:13 10.
    Treated HeLa cells with 8 stressors followed by the examination of universally expressed circRNAs
  • 01:00 11.
    circRNAs are degraded upon Poly I:C treatment
  • 02:17 12.
    Treated HeLa cells with 8 stressors followed by the examination of universally expressed circRNAs
  • 00:01 13.
    circRNAs are degraded upon Poly I:C treatment
  • 00:08 14.
    Global reduction of high confidence circRNAs upon poly(I:C) for 6 h (C) or EMCV for 24 h
  • 00:00 15.
    circRNAs are degraded upon Poly I:C treatment
  • 04:06 16.
    Global reduction of high confidence circRNAs upon poly(I:C) for 6 h (C) or EMCV for 24 h
  • 00:00 17.
    circRNAs are degraded upon Poly I:C treatment
  • 00:00 18.
    Treated HeLa cells with 8 stressors followed by the examination of universally expressed circRNAs
  • 00:01 19.
    circRNAs are degraded upon Poly I:C treatment
  • 00:07 20.
    Global reduction of high confidence circRNAs upon poly(I:C) for 6 h (C) or EMCV for 24 h
  • 00:14 21.
    Slide 9
  • 03:19 22.
    RNase L “may” be responsible for circRNA degradation upon poly(I:C) and viral stimulations
  • 00:01 23.
    Slide 9
  • 00:27 24.
    RNase L “may” be responsible for circRNA degradation upon poly(I:C) and viral stimulations
  • 00:02 25.
    Slide 11
  • 00:05 26.
    RNase L “may” be responsible for circRNA degradation upon poly(I:C) and viral stimulations
  • 02:01 27.
    Slide 11
  • 01:39 28.
    RNase L is responsible for global circRNA degradation in cells treated with poly(I:C)
  • 00:33 29.
    The endonuclease activity of RNase L is requiredfor circRNA degradation
  • 00:00 30.
    Slide 14
  • 01:42 31.
    The endonuclease activity of RNase L is requiredfor circRNA degradation
  • 00:00 32.
    Slide 14
  • 00:13 33.
    The endonuclease activity of RNase L is requiredfor circRNA degradation
  • 00:05 34.
    Slide 14
  • 00:01 35.
    The endonuclease activity of RNase L is requiredfor circRNA degradation
  • 00:11 36.
    Slide 14
  • 00:10 37.
    Slide 15
  • 00:02 38.
    In vitro binding and competition screening assays with purified immune factors
  • 00:22 39.
    Slide 15
  • 01:22 40.
    In vitro binding and competition screening assays with purified immune factors
  • 00:04 41.
    Slide 15
  • 00:48 42.
    In vitro binding and competition screening assays with purified immune factors
  • 05:37 43.
    circRNAs prefer to bind to nucleic acid receptors with antiviral activity
  • 00:06 44.
    circRNAs prefer to bind to nucleic acid receptors with antiviral activity
  • 00:00 45.
    circRNAs prefer to bind to nucleic acid receptors with antiviral activity
  • 00:01 46.
    circRNAs prefer to bind to nucleic acid receptors with antiviral activity
  • 00:00 47.
    dsRBMs of PKR are required for binding to circPOLR2A
  • 00:29 48.
    circRNAs prefer to bind to nucleic acid receptors with antiviral activity
  • 01:48 49.
    dsRBMs of PKR are required for binding to circPOLR2A
  • 00:00 50.
    circRNAs prefer to bind to nucleic acid receptors with antiviral activity
  • 00:00 51.
    circRNAs prefer to bind to nucleic acid receptors with antiviral activity
  • 00:33 52.
    circRNAs prefer to bind to nucleic acid receptors with antiviral activity
  • 00:01 53.
    dsRBMs of PKR are required for binding to circPOLR2A
  • 00:19 54.
    circRNAs prefer to bind to nucleic acid receptors with antiviral activity
  • 00:00 55.
    dsRBMs of PKR are required for binding to circPOLR2A
  • 00:41 56.
    PKR is an IFN-inducible Ser/Thr protein kinase directly activated by dsRNA
  • 02:04 57.
    Slide 21
  • 00:11 58.
    Slide 22
  • 00:00 59.
    Slide 23
  • 00:01 60.
    Slide 22
  • 00:25 61.
    Slide 23
  • 01:02 62.
    Slide 24
  • 00:02 63.
    Comparison of paired circular and linear RNA structures by SHAPE-MaP
  • 00:24 64.
    Slide 24
  • 01:12 65.
    Comparison of paired circular and linear RNA structures by SHAPE-MaP
  • 01:13 66.
    Linear POLR2A is relatively unstructured within circPOLR2A-forming region
  • 00:31 67.
    circRNAs have distinct structural conformation from their linear cognate RNAs
  • 00:32 68.
    Many examined circRNAs tend to form imperfect duplex RNA regions
  • 00:03 69.
    Slide 29
  • 01:12 70.
    Slide 30
  • 00:28 71.
    Slide 31
  • 00:08 72.
    Slide 32
  • 00:20 73.
    Slide 33
  • 01:20 74.
    Most examined circRNAs could form 1–4 dsRNA regions.Hypothesis : Per cell may contains > 10,000~20,000 intra-dsRNA regions and that such circRNAs represent a type of endogenous inhibitors for PKR.
  • 00:38 75.
    Overexpression of circRNAs in Hela cell
  • 00:04 76.
    Most examined circRNAs could form 1–4 dsRNA regions.Hypothesis : Per cell may contains > 10,000~20,000 intra-dsRNA regions and that such circRNAs represent a type of endogenous inhibitors for PKR.
  • 00:28 77.
    Overexpression of circRNAs in Hela cell
  • 00:58 78.
    Overexpression of circPOLR2A in HeLa cells inhibits PKR phosphorylation upon poly(I:C) stimulation
  • 01:25 79.
    Overexpression of the non-dsRNA-containing circRNA in HeLa cells does not suppress PKR phosphorylation upon poly(I:C) stimulation.
  • 00:22 80.
    Slide 38
  • 00:01 81.
    Slide 39
  • 00:00 82.
    Reduced PKR activation in RNase L KO HeLa cells stimulated with poly(I:C)
  • 00:25 83.
    Slide 39
  • 00:41 84.
    Reduced PKR activation in RNase L KO HeLa cells stimulated with poly(I:C)
  • 00:22 85.
    Overexpression of circPOLR2A in HeLa cells inhibitsPKR phosphorylation upon EMCV infection
  • 00:07 86.
    Slide 42
  • 01:28 87.
    Dysregulated circRNA expression and PKR activation in SLE
  • 00:28 88.
    circRNA reduction in PBMCs derived from SLE patients
  • 01:45 89.
    Slide 45
  • 00:37 90.
    Global reduction of circRNA expression in SLE patients (RNA-seq)
  • 00:29 91.
    Slide 47
  • 01:02 92.
    circPOLR2A overexpression attenuates aberrant PKR and EIF2α phosphorylation in PBMCs isolated from three SLE patients
  • 00:00 93.
    circPOLR2A overexpression attenuates aberrant PKR and EIF2α phosphorylation in T cells isolated from three SLE patients
  • 00:15 94.
    circPOLR2A overexpression attenuates aberrant PKR and EIF2α phosphorylation in PBMCs isolated from three SLE patients
  • 00:04 95.
    circPOLR2A overexpression attenuates aberrant PKR and EIF2α phosphorylation in T cells isolated from three SLE patients
  • 00:03 96.
    circPOLR2A overexpression attenuates aberrant PKR and EIF2α phosphorylation in PBMCs isolated from three SLE patients
  • 00:07 97.
    circPOLR2A overexpression attenuates aberrant PKR and EIF2α phosphorylation in T cells isolated from three SLE patients
  • 00:12 98.
    Conclusion
  • 00:51 99.
    Slide 51
  • 00:30 100.
    Highlights
  • 00:51 101.
    circPOLR2A overexpression attenuates aberrant PKR and EIF2α phosphorylation in PBMCs isolated from three SLE patients
  • Index
  • Notes
  • Comment
  • Fullscreen
20190520-lab meeting_捷登
Duration: 1:07:08, Browse: 491, Last Updated: 2019-06-13
Attachment(s):
Keypoint
  1. 1.
    f8bf050378a020b030249b59422e37af.png
    Prev Next
    • 00:59 1.
      index 1
    • 00:27 2.
      Slide 2
    • 01:35 3.
      Introduction
    • 01:17 4.
      Slide 4
    • 00:39 5.
      Examination of universally expressed circRNAs
    • 02:11 6.
      Treated HeLa cells with 8 stressors followed by the examination of universally expressed circRNAs
    • 01:01 7.
      circRNAs are degraded upon Poly I:C treatment
    • 00:00 8.
      Global reduction of high confidence circRNAs upon poly(I:C) for 6 h (C) or EMCV for 24 h
    • 00:59 9.
      circRNAs are degraded upon Poly I:C treatment
    • 01:13 10.
      Treated HeLa cells with 8 stressors followed by the examination of universally expressed circRNAs
    • 01:00 11.
      circRNAs are degraded upon Poly I:C treatment
    • 02:17 12.
      Treated HeLa cells with 8 stressors followed by the examination of universally expressed circRNAs
    • 00:01 13.
      circRNAs are degraded upon Poly I:C treatment
    • 00:08 14.
      Global reduction of high confidence circRNAs upon poly(I:C) for 6 h (C) or EMCV for 24 h
    • 00:00 15.
      circRNAs are degraded upon Poly I:C treatment
    • 04:06 16.
      Global reduction of high confidence circRNAs upon poly(I:C) for 6 h (C) or EMCV for 24 h
    • 00:00 17.
      circRNAs are degraded upon Poly I:C treatment
    • 00:00 18.
      Treated HeLa cells with 8 stressors followed by the examination of universally expressed circRNAs
    • 00:01 19.
      circRNAs are degraded upon Poly I:C treatment
    • 00:07 20.
      Global reduction of high confidence circRNAs upon poly(I:C) for 6 h (C) or EMCV for 24 h
    • 00:14 21.
      Slide 9
    • 03:19 22.
      RNase L “may” be responsible for circRNA degradation upon poly(I:C) and viral stimulations
    • 00:01 23.
      Slide 9
    • 00:27 24.
      RNase L “may” be responsible for circRNA degradation upon poly(I:C) and viral stimulations
    • 00:02 25.
      Slide 11
    • 00:05 26.
      RNase L “may” be responsible for circRNA degradation upon poly(I:C) and viral stimulations
    • 02:01 27.
      Slide 11
    • 01:39 28.
      RNase L is responsible for global circRNA degradation in cells treated with poly(I:C)
    • 00:33 29.
      The endonuclease activity of RNase L is requiredfor circRNA degradation
    • 00:00 30.
      Slide 14
    • 01:42 31.
      The endonuclease activity of RNase L is requiredfor circRNA degradation
    • 00:00 32.
      Slide 14
    • 00:13 33.
      The endonuclease activity of RNase L is requiredfor circRNA degradation
    • 00:05 34.
      Slide 14
    • 00:01 35.
      The endonuclease activity of RNase L is requiredfor circRNA degradation
    • 00:11 36.
      Slide 14
    • 00:10 37.
      Slide 15
    • 00:02 38.
      In vitro binding and competition screening assays with purified immune factors
    • 00:22 39.
      Slide 15
    • 01:22 40.
      In vitro binding and competition screening assays with purified immune factors
    • 00:04 41.
      Slide 15
    • 00:48 42.
      In vitro binding and competition screening assays with purified immune factors
    • 05:37 43.
      circRNAs prefer to bind to nucleic acid receptors with antiviral activity
    • 00:06 44.
      circRNAs prefer to bind to nucleic acid receptors with antiviral activity
    • 00:00 45.
      circRNAs prefer to bind to nucleic acid receptors with antiviral activity
    • 00:01 46.
      circRNAs prefer to bind to nucleic acid receptors with antiviral activity
    • 00:00 47.
      dsRBMs of PKR are required for binding to circPOLR2A
    • 00:29 48.
      circRNAs prefer to bind to nucleic acid receptors with antiviral activity
    • 01:48 49.
      dsRBMs of PKR are required for binding to circPOLR2A
    • 00:00 50.
      circRNAs prefer to bind to nucleic acid receptors with antiviral activity
    • 00:00 51.
      circRNAs prefer to bind to nucleic acid receptors with antiviral activity
    • 00:33 52.
      circRNAs prefer to bind to nucleic acid receptors with antiviral activity
    • 00:01 53.
      dsRBMs of PKR are required for binding to circPOLR2A
    • 00:19 54.
      circRNAs prefer to bind to nucleic acid receptors with antiviral activity
    • 00:00 55.
      dsRBMs of PKR are required for binding to circPOLR2A
    • 00:41 56.
      PKR is an IFN-inducible Ser/Thr protein kinase directly activated by dsRNA
    • 02:04 57.
      Slide 21
    • 00:11 58.
      Slide 22
    • 00:00 59.
      Slide 23
    • 00:01 60.
      Slide 22
    • 00:25 61.
      Slide 23
    • 01:02 62.
      Slide 24
    • 00:02 63.
      Comparison of paired circular and linear RNA structures by SHAPE-MaP
    • 00:24 64.
      Slide 24
    • 01:12 65.
      Comparison of paired circular and linear RNA structures by SHAPE-MaP
    • 01:13 66.
      Linear POLR2A is relatively unstructured within circPOLR2A-forming region
    • 00:31 67.
      circRNAs have distinct structural conformation from their linear cognate RNAs
    • 00:32 68.
      Many examined circRNAs tend to form imperfect duplex RNA regions
    • 00:03 69.
      Slide 29
    • 01:12 70.
      Slide 30
    • 00:28 71.
      Slide 31
    • 00:08 72.
      Slide 32
    • 00:20 73.
      Slide 33
    • 01:20 74.
      Most examined circRNAs could form 1–4 dsRNA regions.Hypothesis : Per cell may contains > 10,000~20,000 intra-dsRNA regions and that such circRNAs represent a type of endogenous inhibitors for PKR.
    • 00:38 75.
      Overexpression of circRNAs in Hela cell
    • 00:04 76.
      Most examined circRNAs could form 1–4 dsRNA regions.Hypothesis : Per cell may contains > 10,000~20,000 intra-dsRNA regions and that such circRNAs represent a type of endogenous inhibitors for PKR.
    • 00:28 77.
      Overexpression of circRNAs in Hela cell
    • 00:58 78.
      Overexpression of circPOLR2A in HeLa cells inhibits PKR phosphorylation upon poly(I:C) stimulation
    • 01:25 79.
      Overexpression of the non-dsRNA-containing circRNA in HeLa cells does not suppress PKR phosphorylation upon poly(I:C) stimulation.
    • 00:22 80.
      Slide 38
    • 00:01 81.
      Slide 39
    • 00:00 82.
      Reduced PKR activation in RNase L KO HeLa cells stimulated with poly(I:C)
    • 00:25 83.
      Slide 39
    • 00:41 84.
      Reduced PKR activation in RNase L KO HeLa cells stimulated with poly(I:C)
    • 00:22 85.
      Overexpression of circPOLR2A in HeLa cells inhibitsPKR phosphorylation upon EMCV infection
    • 00:07 86.
      Slide 42
    • 01:28 87.
      Dysregulated circRNA expression and PKR activation in SLE
    • 00:28 88.
      circRNA reduction in PBMCs derived from SLE patients
    • 01:45 89.
      Slide 45
    • 00:37 90.
      Global reduction of circRNA expression in SLE patients (RNA-seq)
    • 00:29 91.
      Slide 47
    • 01:02 92.
      circPOLR2A overexpression attenuates aberrant PKR and EIF2α phosphorylation in PBMCs isolated from three SLE patients
    • 00:00 93.
      circPOLR2A overexpression attenuates aberrant PKR and EIF2α phosphorylation in T cells isolated from three SLE patients
    • 00:15 94.
      circPOLR2A overexpression attenuates aberrant PKR and EIF2α phosphorylation in PBMCs isolated from three SLE patients
    • 00:04 95.
      circPOLR2A overexpression attenuates aberrant PKR and EIF2α phosphorylation in T cells isolated from three SLE patients
    • 00:03 96.
      circPOLR2A overexpression attenuates aberrant PKR and EIF2α phosphorylation in PBMCs isolated from three SLE patients
    • 00:07 97.
      circPOLR2A overexpression attenuates aberrant PKR and EIF2α phosphorylation in T cells isolated from three SLE patients
    • 00:12 98.
      Conclusion
    • 00:51 99.
      Slide 51
    • 00:30 100.
      Highlights
    • 00:51 101.
      circPOLR2A overexpression attenuates aberrant PKR and EIF2α phosphorylation in PBMCs isolated from three SLE patients
    Location
    1. Media Center
    2. ...
    3. 2019
    Folder name
    2019
    Author
    鄭捷登
    Branch
    賴亮全教授
    Created
    2019-05-20 10:33:55
    Last Updated
    2019-06-13 12:49:55
    Browse
    491
    Duration
    1:07:08
    1. Media Center
    2. ...
    3. 2019